MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.390
-0.010 (-0.71%)
At close: Sep 8, 2025, 4:00 PM
1.380
-0.010 (-0.72%)
After-hours: Sep 8, 2025, 4:10 PM EDT
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $26.51 million as of September 8, 2025. Its market cap has decreased by -7.56% in one year.
Market Cap
26.51M
Enterprise Value
25.67M
1-Year Change
-7.56%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $26.51M, a decrease of -74.32%. That is a compound annual growth rate of -47.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 26.70M | 41.41% |
| Dec 31, 2024 | 18.88M | 21.65% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |